EMA commentary on the ICH guideline for testing for carcinogenicity of pharmaceuticals

Author:

van der Laan Jan Willem123,Andersson Mikael4,Beken Sonja5,Bonelli Milton6,Brendler‐Schwaab Susanne7,Kane Rosemary8,Pasanen Markku29,Ponzano Stefano6,Paur Jakob10,Siezen Christine1,Soleng Anne11,Whomsley Rhys6ORCID

Affiliation:

1. Medicines Evaluation Board Utrecht The Netherlands

2. ICH S1 Expert Working Group European Medicines Agency Amsterdam The Netherlands

3. Division of Drug Discovery and Safety Leiden Academic Centre for Drug Research, University of Leiden Leiden Netherlands

4. Medical Products Agency Uppsala Sweden

5. Federal Agency for Medicines and Health Products Brussels Belgium

6. European Medicines Agency Amsterdam The Netherlands

7. Federal Institute for Drugs and Medical Devices (BfArM) Bonn Germany

8. Health Products Regulatory Authority Dublin Ireland

9. School of Pharmacy University of Eastern Finland Kuopio Finland

10. Austrian Medicines and Medical Devices Agency (AGES) Vienna Austria

11. Norwegian Medicines Agency Oslo Norway

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference44 articles.

1. ICH topic S1B. Testing for carcinogenicity of pharmaceuticals part II S1B‐R1_FinalGuideline_2022_0719.pdf(ich.org).

2. ICH S1A. Guideline on the need for carcinogenicity studies of pharmaceuticals.S1A Guideline.pdf(ich.org) (checked February 28 2023).

3. ICH topic S1B. Carcinogenicity: testing for carcinogenicity of pharmaceuticals. Step 4 consensus guideline. Part I.S1B‐R1_FinalGuideline_2022_0719.pdf(ich.org).

4. ICH topic S1C. Dose selection for carcinogenicity studies of pharmaceuticals.S1C(R2) Guideline.pdf(ich.org) (checked February 28 2023).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3